Expanded strategic and operational leadership positions Zenas for growth as obexelimab advances in late-stage clinical trials for multiple potential I&I indications WALTHAM, Mass., Dec. 04,

A Media Snippet accompanying this announcement is available by clicking on this link. Most successful dinosaur exhibit of all-time More than 1.5 million visitors see